This study aimed to explore the relationships between serum apolipoprotein A1 (ApoA1) and B (ApoB) levels and the ApoB/A1 ratio with structural and vascular changes in the retinas of patients with diabetic macular edema (DME), as assessed through optical coherence tomography (OCT) and OCT angiography (OCTA). 62 eyes from 38 treatment-naive diabetic retinopathy patients were assessed. Baseline and 6-month evaluations included clinical exams, fundus photography, blood tests for cholesterol, ApoA1, and ApoB, as well as imaging with OCT and OCTA. Associations between apolipoproteins and changes in central retinal thickness (CRT), foveal avascular zone (FAZ), and vessel/perfusion density were analyzed. In DME patients, elevated ApoB levels (>122.5 mg/dL) were significantly linked with increased CRT, FAZ expansion, and reduced perfusion density at the 6-month follow-up (p = 0.026, 0.046, and 0.025). Higher ApoB/A1 ratio (>0.85) was significantly associated with decreased perfusion density (p = 0.011). Elevated ApoB levels and ApoB/A1 ratio were linked with reduced perfusion and vessel density, increased CRT, and FAZ expansion, highlighting their potential as negative biomarkers for OCT-detected retinomacular changes.
Purpose: This review aims to clarify the role of ophthalmic steroids in polypoidal choroidal vasculopathy (PCV) treatment. Methods: A systematic literature search was performed using Scopus, PubMed, MEDLINE, Cochrane, ProQuest, and manual searches. The primary outcome was changes in best-corrected visual acuity. The secondary outcomes were anatomical changes and incidence of adverse events. Results: Of the 100 articles identified, 9 studies were included: six treatment-naive studies, two anti-VEGF resistant studies, and one involving hemorrhagic retinal detachment. Triamcinolone acetonide was administered in seven studies, and dexamethasone in two. Altogether, 194 eyes received ophthalmic steroids in the form of intravitreal solution and slow-released implant. Overall, eight out of nine studies revealed visual acuity improvement from baseline to final follow-up, although only two studies reported significant results (0.33 ± 0.29 logMAR and 0.66 ± 0.28 logMAR) to final follow-up (0.16 ± 0.27 logMAR and 0.36 ± 0.31 logMAR). Adverse events were documented in six studies, with cataracts (6/96) and ocular hypertension (10/96) being the most common. Polyp regression and pigment epithelial detachment rates demonstrated a decline ranging from 50% to 100%. The maximum reduction observed in the central foveal thickness and central retinal thickness was − 131.4 μm and − 261.7 μm, respectively. Conclusion: Ophthalmic steroids may serve as an effective adjunctive treatment for PCV patients, irrespective of anti-VEGF resistance or hemorrhagic involvement, and may be considered as a potential monotherapy in resource-limited settings, with minimal side effects.
Intraocular foreign bodies (IOFB) remain a significant cause of visual impairment worldwide. The complex nature of IOFB cases poses considerable management challenges, contributing to various outcomes. This study aimed to determine clinical characteristics and prognostic factors associated with visual outcomes following IOFB treatments. We conducted a retrospective review of IOFB patients admitted between January 2019 - January 2024 at a tertiary hospital in Indonesia. Medical records were evaluated based on predefined inclusion and exclusion criteria. A total of forty-six patients (46 eyes) were analyzed, of which 76.1% had metallic IOFBs (35 eyes), predominantly caused by hammering metal (70%). Cornea was the most frequent entry site (31 eyes). The mean preoperative best-corrected visual acuity (BCVA) was 1.74 ± 1.01 (logMAR), improving to 1.28 ± 1.03 at the final follow-up. Univariate analysis showed larger IOFB size, worse initial BCVA, longer injury-to-surgery intervals, higher complications, endophthalmitis, traumatic cataract, secondary glaucoma, and primary surgery with lensectomy were significantly associated with poor final BCVA. Multiple logistic regression identified poor baseline BCVA and the need of additional lensectomy procedure as independent risk factors for lower final BCVA. Lower preoperative BCVA and concomitant lensectomy subsequent to IOFB removal were significant predictors of poor visual prognosis. IOFBs are a major cause of visual loss in open-globe injuries, with visual outcomes influenced by factors such as IOFB size, material, location, associated complications, and timing of surgery. However, data from Indonesia remain limited despite a high burden of ocular trauma in the region. This study shows that poor baseline visual acuity and concomitant lensectomy at the time of IOFB removal are independent predictors of poor final visual outcome. It also highlights the predominance of metal-related IOFBs, mostly caused by welding accidents, among young adult males. These findings emphasize the importance of early prognostication and patient counseling based on baseline vision and surgical planning. It also reinforces the need for occupational safety measures, particularly mandatory protective eyewear in high-risk jobs, and for strengthening early detection and referral systems in resource-limited settings.
Macular hole (MH) surgery generally has a high success rate, but finding anatomical plug for refractory cases remains challenging. The human amniotic membrane (hAM), with its anti-inflammatory and regenerative properties, has emerged as a potential option. This study aims to report the anatomical and functional outcomes of human amniotic membrane (hAM) graft as an intervention to repair refractory macular hole cases where wide internal limiting membrane (ILM) peeling was unsuccessful. A retrospective chart review was conducted at a single center, with the main outcomes being closure rate and postoperative BCVA at 6 months. Eleven eyes of 11 patients with refractory macular holes were identified and included in the study. Participants were predominantly males (72.73%) with a mean age of 49.27 years. Nine eyes achieved successful MH closure with a single intervention and showed no recurrence during the 6-month follow-up. Mean BCVA at 3 and 6 months improved significantly (p = 0.0207) from 1.747 ± 0.74 logMAR to 1.210 ± 0.51 logMAR and 0.939 ± 0.47 logMAR (range 2.079–0.301 logMAR). The use of human amniotic membrane (hAM) graft seems to be a viable and effective alternative for the treatment of refractory macular holes. However, further larger prospective controlled studies are necessary to confirm our results.